|
市場調査レポート
商品コード
1540957
アブレーションデバイス市場レポート：デバイス技術、用途、エンドユーザー、地域別、2024年～2032年Ablation Devices Market Report by Device Technology, Application, End User, and Region 2024-2032 |
||||||
カスタマイズ可能
|
|||||||
| アブレーションデバイス市場レポート：デバイス技術、用途、エンドユーザー、地域別、2024年～2032年 |
|
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 141 Pages
納期: 2～3営業日
|
- 全表示
- 概要
- 図表
- 目次
世界のアブレーションデバイス市場規模は2023年に59億米ドルに達しました。今後、IMARC Groupは、2024年から2032年にかけての成長率（CAGR）は10.2％を示し、2032年には144億米ドルに達すると予測しています。生命を脅かす疾患の主な発展、異常組織を除去するための電気生理学の普及、ロボットナビゲーションシステムを備えた次世代アブレーションデバイスの開拓などが、市場を牽引する主な要因です。
アブレーション機器は、一般的に特定の病状を治療または管理する目的で、組織を除去または破壊する様々な医療処置に使用される医療器具またはツールです。これらの器具は、熱、冷却、高周波などのエネルギーを標的組織に与え、その除去や変化を引き起こすことで機能します。アブレーション手術は低侵襲で、一般的に痛みが少なく、回復に要する時間が短く、合併症のリスクが低いため、従来の外科的方法よりも好まれることが多いです。
この市場は、がん、心房細動、慢性静脈不全（CVI）などの生命を脅かす疾患の有病率の増加など、いくつかの重要な要因によって成長を遂げています。このような疾患罹患率の増加は、効果的なアブレーション手技に対する需要を強調しています。さらに、低侵襲のアブレーション技術が利用可能であることに対する一般市民の意識の高まりが、市場の拡大を後押ししています。これらの手技には、痛みの軽減、傷跡の最小化、不快感の軽減、患者の回復時間の短縮など、数多くの利点があります。さらに、異常組織を除去することで不整脈や心筋梗塞に対処する電気生理学的処置が広く採用されていることも、市場の成長に大きく寄与しています。また、メーカーは、表在静脈逆流を効果的に治療するために調整された非熱、非粘液、非凝固剤の静脈内アブレーション装置を開発することで、進化する医療ニーズに応えています。
アブレーションデバイス市場傾向/促進要因：
生命を脅かす疾患の増加
がんは依然として世界の主要死因の1つであり、その罹患率は近年上昇傾向にあります。特に腫瘍学において、切除術は外科手術に代わる低侵襲の治療法として脚光を浴びています。肝臓、腎臓、肺など様々な臓器のがん組織を破壊するために採用されています。また、CVIとは、足の静脈が血液を心臓に十分に戻すことができなくなり、痛み、腫れ、皮膚の変化を引き起こす疾患です。静脈内焼灼術は、機能不全に陥った静脈を閉鎖することによってCVIを治療する方法として、現在一般的に用いられています。生活習慣や加齢に伴うCVIの増加により、静脈治療用のアブレーション機器の需要が高まっています。
電気生理学の普及
電気生理学は心臓の電気的活動を扱う循環器学の一分野です。心房細動を含むさまざまな心臓不整脈の診断と治療に有効であることから、採用が急増しています。電気生理学的誘導によるアブレーション治療では、心臓の異常な電気信号の発生源を正確に突き止め、除去します。この方法は多くの心臓リズム障害に対する標準治療となっており、患者に症状の緩和と生活の質の向上の機会を提供しています。さらに、電気生理学的ガイド下アブレーションの有用性を認識する医療関係者の増加に伴い、アブレーションは広く普及し、関連するアブレーション機器や装置の需要も高まっています。
次世代アブレーション機器とロボットナビゲーションシステムの統合
アブレーション機器の分野では、技術の進歩が大きな原動力となっています。次世代アブレーション機器にはロボットナビゲーションシステムが組み込まれており、精度、正確性、治療成績が向上しています。ロボット支援アブレーションは、より制御された標的組織切除を可能にし、合併症のリスクを低減し、患者の転帰を改善します。これらのロボットシステムは、治療領域のリアルタイム画像とマッピングを提供し、ヘルスケアプロバイダーが複雑な解剖学的構造をより確実にナビゲートできるようにします。その結果、特に最先端の治療オプションを提供しようとするヘルスケア施設の間で、これらの先進的アブレーション装置の採用が増加しています。患者の安全性と手技の成功率の向上が期待できることから、これらの機器に対する需要はさらに高まっています。
目次
第1章 序文
第2章 調査範囲と調査手法
- 調査の目的
- ステークホルダー
- データソース
- 一次情報
- 二次情報
- 市場推定
- ボトムアップアプローチ
- トップダウンアプローチ
- 調査手法
第3章 エグゼクティブサマリー
第4章 イントロダクション
- 概要
- 主要業界動向
第5章 世界のアブレーションデバイス市場
- 市場概要
- 市場実績
- COVID-19の影響
- 市場予測
第6章 市場内訳：デバイステクノロジー
- 無線周波数デバイス
- 市場動向
- 市場予測
- レーザー/光アブレーション
- 市場動向
- 市場予測
- 超音波装置
- 市場動向
- 市場予測
- 凍結アブレーション装置
- 市場動向
- 市場予測
- その他
- 市場動向
- 市場予測
第7章 市場内訳：用途別
- がん治療
- 市場動向
- 市場予測
- 心臓血管疾患の治療
- 市場動向
- 市場予測
- 眼科治療
- 市場動向
- 市場予測
- 婦人科治療
- 市場動向
- 市場予測
- 泌尿器科治療
- 市場動向
- 市場予測
- 美容整形
- 市場動向
- 市場予測
- その他
- 市場動向
- 市場予測
第8章 市場内訳：エンドユーザー別
- 病院
- 市場動向
- 市場予測
- 外来手術センター
- 市場動向
- 市場予測
- その他
- 市場動向
- 市場予測
第9章 市場内訳：地域別
- 北米
- 米国
- カナダ
- アジア太平洋
- 中国
- 日本
- インド
- 韓国
- オーストラリア
- インドネシア
- その他
- 欧州
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- ロシア
- その他
- ラテンアメリカ
- ブラジル
- メキシコ
- その他
- 中東・アフリカ
- 市場動向
- 市場内訳：国別
- 市場予測
第10章 SWOT分析
- 概要
- 強み
- 弱み
- 機会
- 脅威
第11章 バリューチェーン分析
第12章 ポーターのファイブフォース分析
- 概要
- 買い手の交渉力
- 供給企業の交渉力
- 競合の程度
- 新規参入業者の脅威
- 代替品の脅威
第13章 価格分析
第14章 競合情勢
- 市場構造
- 主要企業
- 主要企業のプロファイル
- Abbott Laboratories
- AngioDynamics Inc.
- AtriCure Inc.
- Boston Scientific Corporation
- CONMED Corporation
- Elekta AB（publ）
- Johnson & Johnson
- Medtronic plc
- Olympus Corporation
- Smith & Nephew plc
List of Figures
- Figure 1: Global: Ablation Devices Market: Major Drivers and Challenges
- Figure 2: Global: Ablation Devices Market: Sales Value (in Billion US$), 2018-2023
- Figure 3: Global: Ablation Devices Market Forecast: Sales Value (in Billion US$), 2024-2032
- Figure 4: Global: Ablation Devices Market: Breakup by Device Technology (in %), 2023
- Figure 5: Global: Ablation Devices Market: Breakup by Application (in %), 2023
- Figure 6: Global: Ablation Devices Market: Breakup by End User (in %), 2023
- Figure 7: Global: Ablation Devices Market: Breakup by Region (in %), 2023
- Figure 8: Global: Ablation Devices (Radiofrequency Devices) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 9: Global: Ablation Devices (Radiofrequency Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 10: Global: Ablation Devices (Laser/Light Ablation) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 11: Global: Ablation Devices (Laser/Light Ablation) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 12: Global: Ablation Devices (Ultrasound Devices) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 13: Global: Ablation Devices (Ultrasound Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 14: Global: Ablation Devices (Cryoablation Devices) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 15: Global: Ablation Devices (Cryoablation Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 16: Global: Ablation Devices (Other Device Technologies) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 17: Global: Ablation Devices (Other Device Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 18: Global: Ablation Devices (Cancer Treatment) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 19: Global: Ablation Devices (Cancer Treatment) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 20: Global: Ablation Devices (Cardiovascular Disease Treatment) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 21: Global: Ablation Devices (Cardiovascular Disease Treatment) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 22: Global: Ablation Devices (Ophthalmologic Treatment) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 23: Global: Ablation Devices (Ophthalmologic Treatment) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 24: Global: Ablation Devices (Gynecological Treatment) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 25: Global: Ablation Devices (Gynecological Treatment) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 26: Global: Ablation Devices (Urological Treatment) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 27: Global: Ablation Devices (Urological Treatment) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 28: Global: Ablation Devices (Cosmetic Surgery) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 29: Global: Ablation Devices (Cosmetic Surgery) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 30: Global: Ablation Devices (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 31: Global: Ablation Devices (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 32: Global: Ablation Devices (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 33: Global: Ablation Devices (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 34: Global: Ablation Devices (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 35: Global: Ablation Devices (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 36: Global: Ablation Devices (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 37: Global: Ablation Devices (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 38: North America: Ablation Devices Market: Sales Value (in Million US$), 2018 & 2023
- Figure 39: North America: Ablation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 40: United States: Ablation Devices Market: Sales Value (in Million US$), 2018 & 2023
- Figure 41: United States: Ablation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 42: Canada: Ablation Devices Market: Sales Value (in Million US$), 2018 & 2023
- Figure 43: Canada: Ablation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 44: Asia-Pacific: Ablation Devices Market: Sales Value (in Million US$), 2018 & 2023
- Figure 45: Asia-Pacific: Ablation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 46: China: Ablation Devices Market: Sales Value (in Million US$), 2018 & 2023
- Figure 47: China: Ablation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 48: Japan: Ablation Devices Market: Sales Value (in Million US$), 2018 & 2023
- Figure 49: Japan: Ablation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 50: India: Ablation Devices Market: Sales Value (in Million US$), 2018 & 2023
- Figure 51: India: Ablation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 52: South Korea: Ablation Devices Market: Sales Value (in Million US$), 2018 & 2023
- Figure 53: South Korea: Ablation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 54: Australia: Ablation Devices Market: Sales Value (in Million US$), 2018 & 2023
- Figure 55: Australia: Ablation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 56: Indonesia: Ablation Devices Market: Sales Value (in Million US$), 2018 & 2023
- Figure 57: Indonesia: Ablation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 58: Others: Ablation Devices Market: Sales Value (in Million US$), 2018 & 2023
- Figure 59: Others: Ablation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 60: Europe: Ablation Devices Market: Sales Value (in Million US$), 2018 & 2023
- Figure 61: Europe: Ablation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 62: Germany: Ablation Devices Market: Sales Value (in Million US$), 2018 & 2023
- Figure 63: Germany: Ablation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 64: France: Ablation Devices Market: Sales Value (in Million US$), 2018 & 2023
- Figure 65: France: Ablation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 66: United Kingdom: Ablation Devices Market: Sales Value (in Million US$), 2018 & 2023
- Figure 67: United Kingdom: Ablation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 68: Italy: Ablation Devices Market: Sales Value (in Million US$), 2018 & 2023
- Figure 69: Italy: Ablation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 70: Spain: Ablation Devices Market: Sales Value (in Million US$), 2018 & 2023
- Figure 71: Spain: Ablation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 72: Russia: Ablation Devices Market: Sales Value (in Million US$), 2018 & 2023
- Figure 73: Russia: Ablation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 74: Others: Ablation Devices Market: Sales Value (in Million US$), 2018 & 2023
- Figure 75: Others: Ablation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 76: Latin America: Ablation Devices Market: Sales Value (in Million US$), 2018 & 2023
- Figure 77: Latin America: Ablation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 78: Brazil: Ablation Devices Market: Sales Value (in Million US$), 2018 & 2023
- Figure 79: Brazil: Ablation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 80: Mexico: Ablation Devices Market: Sales Value (in Million US$), 2018 & 2023
- Figure 81: Mexico: Ablation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 82: Others: Ablation Devices Market: Sales Value (in Million US$), 2018 & 2023
- Figure 83: Others: Ablation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 84: Middle East and Africa: Ablation Devices Market: Sales Value (in Million US$), 2018 & 2023
- Figure 85: Middle East and Africa: Ablation Devices Market: Breakup by Country (in %), 2023
- Figure 86: Middle East and Africa: Ablation Devices Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 87: Global: Ablation Devices Industry: SWOT Analysis
- Figure 88: Global: Ablation Devices Industry: Value Chain Analysis
- Figure 89: Global: Ablation Devices Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Ablation Devices Market: Key Industry Highlights, 2023 and 2032
- Table 2: Global: Ablation Devices Market Forecast: Breakup by Device Technology (in Million US$), 2024-2032
- Table 3: Global: Ablation Devices Market Forecast: Breakup by Application (in Million US$), 2024-2032
- Table 4: Global: Ablation Devices Market Forecast: Breakup by End User (in Million US$), 2024-2032
- Table 5: Global: Ablation Devices Market Forecast: Breakup by Region (in Million US$), 2024-2032
- Table 6: Global: Ablation Devices Market: Competitive Structure
- Table 7: Global: Ablation Devices Market: Key Players
The global ablation devices market size reached US$ 5.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 14.4 Billion by 2032, exhibiting a growth rate (CAGR) of 10.2% during 2024-2032. The increasing prevalence of life-threatening diseases, the widespread adoption of electrophysiology to remove abnormal tissues, and the development of next-generation ablation devices with robotic navigation systems represent some of the key factors driving the market.
Ablation devices are medical instruments or tools used in various medical procedures to remove or destroy tissue, typically with the goal of treating or managing certain medical conditions. These devices work by delivering energy, such as heat, cold, or radiofrequency, to the targeted tissue, causing its removal or alteration. Ablation procedures are minimally invasive and are often preferred over traditional surgical methods because they typically result in less pain, shorter recovery times, and reduced risk of complications.
The market is experiencing growth driven by several key factors, including the increasing prevalence of life-threatening diseases such as cancer, atrial fibrillation, and chronic venous insufficiency (CVI). This rise in disease incidence underscores the demand for effective ablation procedures. Furthermore, the growing awareness among the public about the availability of minimally invasive ablation techniques is propelling market expansion. These procedures offer numerous advantages, including reduced pain, minimal scarring, decreased discomfort, and quicker patient recovery times. Additionally, the widespread adoption of electrophysiology procedures to address irregular heart rhythms and cardiac arrhythmia by removing abnormal tissues is contributing significantly to market growth. Besides, manufacturers are also responding to evolving medical needs by creating non-thermal, non-tumescent, and non-sclerosant endovenous ablation devices tailored for the effective treatment of superficial vein reflux.
Ablation Devices Market Trends/Drivers:
Increasing prevalence of life-threatening diseases
Cancer remains one of the leading causes of death worldwide, with a rising incidence in recent years. Ablation procedures, particularly in oncology, have gained prominence as minimally invasive alternatives to surgery. They are employed to destroy cancerous tissues in various organs, such as the liver, kidney, and lung. Moreover, CVI is a condition where veins in the legs fail to adequately return blood to the heart, leading to pain, swelling, and skin changes. Endovenous ablation procedures are now commonly used to treat CVI by closing off malfunctioning veins. The rising incidence of CVI, often associated with lifestyle factors and aging, has driven the demand for ablation devices designed for venous treatments.
Widespread adoption of electrophysiology
Electrophysiology is a branch of cardiology that deals with the electrical activity of the heart. It has witnessed a surge in adoption due to its effectiveness in diagnosing and treating various cardiac arrhythmias, including atrial fibrillation. Electrophysiology-guided ablation procedures involve precisely locating and eliminating the source of abnormal electrical signals in the heart. This approach has become the standard of care for many heart rhythm disorders, offering patients a chance for symptom relief and improved quality of life. Moreover, with healthcare professionals increasingly recognizing the benefits of electrophysiology-guided ablation, its adoption has become widespread, leading to a growing demand for related ablation devices and equipment.
Integration of next-generation ablation devices with robotic navigation systems
The advancement of technology in the field of ablation devices is a significant driving force. Next-generation ablation devices incorporate robotic navigation systems, which enhance precision, accuracy, and procedural outcomes. Robotic-assisted ablation allows for more controlled and targeted tissue ablation, reducing the risk of complications and improving patient outcomes. These robotic systems provide real-time imaging and mapping of the treatment area, enabling healthcare providers to navigate complex anatomical structures with greater confidence. As a result, the adoption of these advanced ablation devices is on the rise, particularly among healthcare facilities looking to offer state-of-the-art treatment options. The promise of improved patient safety and procedural success rates further fuels the demand for these devices.
Ablation Devices Industry Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global ablation devices market report, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on device technology, application and end user.
Breakup by Device Technology:
Radiofrequency Devices
Laser/Light Ablation
Ultrasound Devices
Cryoablation Devices
Others
Radiofrequency devices represent the most used device technology
The report has provided a detailed breakup and analysis of the market based on the device technology. This includes radiofrequency devices, laser/light ablation, ultrasound devices, cryoablation devices, and others. According to the report, radiofrequency devices represented the largest segment.
RF ablation has demonstrated effectiveness across a wide range of medical applications. It is used to treat conditions such as cardiac arrhythmias (e.g., atrial fibrillation), liver tumors, kidney tumors, and chronic pain management. This versatility makes RF technology a go-to choice for physicians dealing with various medical specialties. Moreover, RF ablation has a long history of safe and successful use in medical procedures. The technology has been refined over the years, and clinicians have extensive experience with its application. This track record of safety and efficacy instills confidence in both healthcare providers and patients.
Breakup by Application:
Cancer Treatment
Cardiovascular Disease Treatment
Ophthalmologic Treatment
Gynecological Treatment
Urological Treatment
Cosmetic Surgery
Others
Cancer treatment holds the largest market share
A detailed breakup and analysis of the market based on the application has also been provided in the report. This includes cancer treatment, cardiovascular disease treatment, ophthalmologic treatment, gynecological treatment, urological treatment, cosmetic surgery, and others. According to the report, cancer treatment represented the largest segment.
Cancer is a widespread and prevalent disease that affects millions of people globally. It can occur in various organs and tissues, leading to a high demand for effective treatment options. As the incidence of cancer continues to rise due to factors like aging populations and lifestyle changes, the need for cancer treatment methods, including ablation, remains significant. Moreover, ablation techniques have proven to be versatile in the field of oncology. These procedures can be used to treat both primary tumors and metastatic lesions, making them applicable across different stages and types of cancer. Ablation can be employed in various organs, such as the liver, kidney, lung, and bone, providing clinicians with a wide range of treatment options.
Breakup by End User:
Hospitals
Ambulatory Surgical Centers
Others
Hospitals accounts for majority of market share
A detailed breakup and analysis of the market based on the end user has also been provided in the report. This includes hospitals, ambulatory surgical centers, and others. According to the report, hospitals represented the largest segment.
Ablation procedures often require specialized equipment and trained medical professionals. Hospitals are well-equipped to handle complex medical interventions and have the necessary infrastructure, including operating rooms, imaging technology, and support staff, to perform these procedures safely and effectively. This makes hospitals the natural choice for patients seeking ablation treatments. Moreover, hospitals house a wide range of medical specialties, including cardiology, oncology, gastroenterology, urology, and more. Ablation devices are used across multiple medical disciplines to treat various conditions. Hospitals can offer a comprehensive suite of ablation services, making them a one-stop destination for patients with diverse medical needs.
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America exhibits a clear dominance in the market
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America, particularly the United States and Canada, boasts a highly developed and advanced healthcare infrastructure. The region is home to world-renowned medical institutions, hospitals, and research centers. This advanced infrastructure provides a solid foundation for the adoption of cutting-edge medical technologies, including ablation devices. Moreover, the region has one of the highest healthcare expenditure rates in the world. This substantial investment in healthcare, both by governments and private entities, enables the procurement of state-of-the-art medical equipment, including ablation devices. It also supports research and development efforts in the healthcare sector, leading to innovation and product advancements.
Competitive Landscape:
The competitive landscape of the market is characterized by the presence of multiple players that include established brands, emerging startups, and specialty manufacturers. Presently, leading companies are allocating significant resources to research and development efforts to develop innovative and technologically advanced ablation devices. This includes the development of next-generation ablation systems with enhanced precision, safety features, and user-friendly interfaces. They are also expanding their product portfolios to offer a comprehensive range of ablation devices catering to various medical specialties and applications. This includes devices designed for cardiac ablation, oncology, pain management, gynecology, and more. Moreover, companies are expanding their reach into new geographical markets. This expansion involves obtaining regulatory approvals and certifications in different regions, establishing distribution networks, and adapting their products to meet specific regional requirements.
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:
Abbott Laboratories
AngioDynamics Inc.
AtriCure Inc.
Boston Scientific Corporation
CONMED Corporation
Elekta AB (publ)
Johnson & Johnson
Medtronic plc
Olympus Corporation
Smith & Nephew plc
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
Recent Developments:
Abbott has made notable developments in the field of ablation devices. They have introduced the EnSite Precision(TM) cardiac mapping system, which offers high-resolution imaging and accurate mapping of the heart. This technology enables precise identification of abnormal tissue during ablation procedures, improving the success rate of the treatment.
Johnson & Johnson has been actively involved in the development of innovative ablation technologies. It has introduced the TactiCath Contact Force Ablation Catheter, which provides real-time feedback on the amount of force applied during cardiac ablation procedures. This helps in achieving better outcomes and reducing the risk of complications.
Medtronic Plc have introduced the Arctic Front Advance Cryoballoon System, which is used for the treatment of atrial fibrillation. This system offers improved efficiency and precision in cardiac ablation procedures.
Key Questions Answered in This Report
- 1. What was the size of the global ablation devices market in 2023?
- 2. What is the expected growth rate of the global ablation devices market during 2024-2032?
- 3. What are the key factors driving the global ablation devices market?
- 4. What has been the impact of COVID-19 on the global ablation devices market?
- 5. What is the breakup of the global ablation devices market based on the device technology?
- 6. What is the breakup of the global ablation devices market based on the application?
- 7. What is the breakup of the global ablation devices market based on the end user?
- 8. What are the key regions in the global ablation devices market?
- 9. Who are the key players/companies in the global ablation devices market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Ablation Devices Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Device Technology
- 6.1 Radiofrequency Devices
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Laser/Light Ablation
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Ultrasound Devices
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Cryoablation Devices
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Others
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
7 Market Breakup by Application
- 7.1 Cancer Treatment
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Cardiovascular Disease Treatment
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Ophthalmologic Treatment
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Gynecological Treatment
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Urological Treatment
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
- 7.6 Cosmetic Surgery
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
- 7.7 Others
- 7.7.1 Market Trends
- 7.7.2 Market Forecast
8 Market Breakup by End User
- 8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Ambulatory Surgical Centers
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Others
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Abbott Laboratories
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 AngioDynamics Inc.
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.2.4 SWOT Analysis
- 14.3.3 AtriCure Inc.
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.3.4 SWOT Analysis
- 14.3.4 Boston Scientific Corporation
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 CONMED Corporation
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 Elekta AB (publ)
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 Johnson & Johnson
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.7.4 SWOT Analysis
- 14.3.8 Medtronic plc
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 Olympus Corporation
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 Smith & Nephew plc
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.10.4 SWOT Analysis
- 14.3.1 Abbott Laboratories
